ViroPharma

Developing and commercializing therapeutics for infectious and orphan diseases

Viropharma was originally an anti-viral therapeutics discovery and development company that eventually became one of the leading specialty pharmaceutical companies focusing on a range of orphan and infectious diseases. Viropharma completed its IPO in 1996 and was acquired by Shire in 2013.

Status

IPO in 1996; Acquired by Shire in 2013

Year of Investment

1996

Strategy

Life Sciences

Subsector

Development-Stage Therapeutics

Location

Exton, Pennsylvania